Ajinomoto Malaysia to be taken private in RM603.4mil delisting proposal
Ajinomoto Co Inc plans to privatise and delist its Malaysian monosodium glutamate subsidiary through a selective capital reduction worth RM603.4mil, offering minority shareholders RM20 per share—a significant premium to recent trading levels.